• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤微环境中的细胞因子-趋化因子网络:对 CSC 特性及治疗应用的影响。

Cytokine chemokine network in tumor microenvironment: Impact on CSC properties and therapeutic applications.

机构信息

Division of Cancer Biology, CSIR-Central Drug Research Institute (CDRI), Lucknow 226031, India.

Division of Cancer Biology, CSIR-Central Drug Research Institute (CDRI), Lucknow 226031, India.

出版信息

Cytokine. 2022 Aug;156:155916. doi: 10.1016/j.cyto.2022.155916. Epub 2022 May 26.

DOI:10.1016/j.cyto.2022.155916
PMID:35644058
Abstract

A subpopulation of cells in many cancers has stem cell traits, mediates metastasis, and contributes to treatment resistance. These cells are considered as cancer stem cells (CSCs). CSC properties of tumor cells are immensely regulated by close interactions with tumor microenvironment components such as mesenchymal stem cells, tumor related fibroblasts, adipocytes, endothelial cells, and immune cells via the intricate network of cytokines, chemokines, and growth factors. Inflammatory cytokines including interleukin (IL)-1, IL-6, and IL-8 play a major role in these interactions via the activation of signal transduction pathways like Stat3/NF-κB etc. in stromal and tumor cells. The activation of these pathways increases the release of more cytokines, resulting in positive feedback loops which help in CSC self-renewal. The pathways controlled by these cytokine loops are similar to those that are active during chronic inflammation and wound healing, suggesting that they might have critical role in establishing relationship between inflammation and cancer. Anti-inflammatory drugs have been identified to inhibit these cytokines and their receptor mediated pathways. These agents have the potential to target CSCs by inhibiting signals from the tumor microenvironment and considered to be a potential candidate for future therapeutics. The significance of cytokines released from the tumor microenvironment in different phases of cancer, as well as their potential application in cancer therapeutics is discussed in this article.

摘要

许多癌症中的细胞亚群具有干细胞特征,介导转移,并导致治疗耐药。这些细胞被认为是癌症干细胞 (CSC)。肿瘤细胞的 CSC 特性受到与肿瘤微环境成分(如间充质干细胞、肿瘤相关成纤维细胞、脂肪细胞、内皮细胞和免疫细胞)的密切相互作用的极大调节,通过细胞因子、趋化因子和生长因子的复杂网络进行调节。包括白细胞介素 (IL)-1、IL-6 和 IL-8 在内的炎症细胞因子通过激活信号转导途径(如 Stat3/NF-κB 等)在基质和肿瘤细胞中发挥主要作用。这些途径的激活增加了更多细胞因子的释放,导致正反馈循环,有助于 CSC 的自我更新。这些细胞因子循环控制的途径与慢性炎症和伤口愈合过程中活跃的途径相似,表明它们可能在炎症和癌症之间的关系建立中起关键作用。已经发现抗炎药物可以抑制这些细胞因子及其受体介导的途径。这些药物通过抑制肿瘤微环境中的信号来靶向 CSC,并被认为是未来治疗的潜在候选药物。本文讨论了肿瘤微环境中释放的细胞因子在癌症不同阶段的重要性,以及它们在癌症治疗中的潜在应用。

相似文献

1
Cytokine chemokine network in tumor microenvironment: Impact on CSC properties and therapeutic applications.肿瘤微环境中的细胞因子-趋化因子网络:对 CSC 特性及治疗应用的影响。
Cytokine. 2022 Aug;156:155916. doi: 10.1016/j.cyto.2022.155916. Epub 2022 May 26.
2
Regulation of cancer stem cells by cytokine networks: attacking cancer's inflammatory roots.细胞因子网络对癌症干细胞的调控:从炎症根源处攻克癌症。
Clin Cancer Res. 2011 Oct 1;17(19):6125-9. doi: 10.1158/1078-0432.CCR-10-2743. Epub 2011 Jun 17.
3
Crosstalk of Inflammatory Cytokines within the Breast Tumor Microenvironment.乳腺肿瘤微环境中的炎症细胞因子串扰。
Int J Mol Sci. 2023 Feb 16;24(4):4002. doi: 10.3390/ijms24044002.
4
Cytokine- and chemokine-induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapy.细胞因子和趋化因子诱导的炎症性结直肠肿瘤微环境:靶向治疗的新途径。
Cancer Commun (Lond). 2022 Aug;42(8):689-715. doi: 10.1002/cac2.12295. Epub 2022 Jul 5.
5
Breast cancer stem cells, cytokine networks, and the tumor microenvironment.乳腺癌干细胞、细胞因子网络与肿瘤微环境。
J Clin Invest. 2011 Oct;121(10):3804-9. doi: 10.1172/JCI57099. Epub 2011 Oct 3.
6
Tumor microenvironment enriches the stemness features: the architectural event of therapy resistance and metastasis.肿瘤微环境丰富了干性特征:治疗抵抗和转移的结构事件。
Mol Cancer. 2022 Dec 22;21(1):225. doi: 10.1186/s12943-022-01682-x.
7
Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.简明综述:CD44在癌症干细胞中的新兴作用:一种有前景的生物标志物和治疗靶点
Stem Cells Transl Med. 2015 Sep;4(9):1033-43. doi: 10.5966/sctm.2015-0048. Epub 2015 Jul 1.
8
Epigenetic Regulation of Inflammatory Cytokine-Induced Epithelial-To-Mesenchymal Cell Transition and Cancer Stem Cell Generation.炎症细胞因子诱导的上皮-间充质细胞转化及癌症干细胞生成的表观遗传调控。
Cells. 2019 Sep 25;8(10):1143. doi: 10.3390/cells8101143.
9
Non-CSCs nourish CSCs through interleukin-17E-mediated activation of NF-κB and JAK/STAT3 signaling in human hepatocellular carcinoma.非癌干细胞通过白细胞介素-17E 介导的 NF-κB 和 JAK/STAT3 信号通路激活来滋养癌干细胞,进而促进人肝癌的发生。
Cancer Lett. 2016 Jun 1;375(2):390-399. doi: 10.1016/j.canlet.2016.03.012. Epub 2016 Mar 18.
10
Stem Cell-Secreted Factors in the Tumor Microenvironment.肿瘤微环境中的干细胞分泌因子。
Adv Exp Med Biol. 2020;1277:115-126. doi: 10.1007/978-3-030-50224-9_8.

引用本文的文献

1
Tumor Microenvironmental Dynamics in Shaping Resistance to Therapeutic Interventions in Melanoma: A Narrative Review.黑色素瘤中肿瘤微环境动力学在塑造对治疗干预的抗性中的作用:一篇综述
Pharmaceuticals (Basel). 2025 Jul 22;18(8):1082. doi: 10.3390/ph18081082.
2
Crosstalk Between Immunity and Oncogenes Within the Tumor Microenvironment of HPV-Associated Cervical Squamous Cell Carcinoma.人乳头瘤病毒相关宫颈鳞状细胞癌肿瘤微环境中免疫与癌基因之间的串扰
Onco Targets Ther. 2025 Aug 15;18:899-920. doi: 10.2147/OTT.S537872. eCollection 2025.
3
Radio-chemotherapy and metformin selectively modulate the heterogeneous landscape of glioma with ribosome biogenesis, long non coding RNA and immune-escape markers as major player.
放射化疗和二甲双胍通过以核糖体生物合成、长链非编码RNA和免疫逃逸标志物为主要因素,选择性地调节胶质瘤的异质性格局。
Int J Biol Sci. 2025 May 27;21(8):3527-3554. doi: 10.7150/ijbs.103194. eCollection 2025.
4
Nanotherapeutic strategies exploiting biological traits of cancer stem cells.利用癌症干细胞生物学特性的纳米治疗策略。
Bioact Mater. 2025 Apr 3;50:61-94. doi: 10.1016/j.bioactmat.2025.03.016. eCollection 2025 Aug.
5
Innovative Therapeutic Approach Targeting Colon Cancer Stem Cells: Transitional Cold Atmospheric Plasma.针对结肠癌干细胞的创新治疗方法:过渡性冷大气等离子体
ACS Omega. 2025 Mar 6;10(12):12109-12121. doi: 10.1021/acsomega.4c10378. eCollection 2025 Apr 1.
6
Deciphering the Role of Cancer Stem Cells: Drivers of Tumor Evolution, Therapeutic Resistance, and Precision Medicine Strategies.解读癌症干细胞的作用:肿瘤进化、治疗抗性及精准医学策略的驱动因素
Cancers (Basel). 2025 Jan 24;17(3):382. doi: 10.3390/cancers17030382.
7
Immunotherapeutic Strategies Targeting Breast Cancer Stem Cells.免疫治疗策略靶向乳腺癌干细胞。
Curr Oncol. 2024 May 29;31(6):3040-3063. doi: 10.3390/curroncol31060232.
8
Editorial: Inflammatory tumor microenvironment: role of cytokines and virokines in breast cancer progression and metastasis.社论:炎性肿瘤微环境:细胞因子和病毒因子在乳腺癌进展和转移中的作用
Front Cell Dev Biol. 2024 Jun 5;12:1414734. doi: 10.3389/fcell.2024.1414734. eCollection 2024.
9
The effect of gD-derived peptides on T cell immune response mediated by BTLA-HVEM protein complex in melanoma patients.gD 衍生肽对黑色素瘤患者 BTLA-HVEM 蛋白复合物介导的 T 细胞免疫反应的影响。
Front Immunol. 2024 May 21;15:1362152. doi: 10.3389/fimmu.2024.1362152. eCollection 2024.
10
Cancer Stem Cells and the Tumor Microenvironment in Tumor Drug Resistance.肿瘤耐药中的癌症干细胞与肿瘤微环境
Stem Cell Rev Rep. 2023 Oct;19(7):2141-2154. doi: 10.1007/s12015-023-10593-3. Epub 2023 Jul 21.